Oncology Pharma Extends Licensing Agreement with NanoSmart Pharmaceuticals, Inc. for Veterinary Oncology
22 févr. 2021 08h00 HE | Oncology Pharma, Inc.
SAN FRANCISCO, CA, Feb. 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Oncology Pharma, Inc. (OTC: ONPH) is pleased to announce that it has extended a world-wide Licensing Agreement with NanoSmart...
Logo.png
PROCESSA PHARMACEUTICALS ENTERED INTO A CONTINGENT PRECEDENT IN-LICENSING AGREEMENT WITH ELION ONCOLOGY FOR THE DEVELOPMENT OF ENILURACIL (PCS6422) FOR THE TREATMENT OF ADVANCED GASTROINTESTINAL TUMORS
27 août 2020 09h30 HE | Processa Pharmaceuticals, Inc.
HANOVER, MD, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (OTCQB: PCSA) announced today that it has entered into a contingent precedent exclusive licensing agreement with Elion...
Logo.jpg
Biofrontera report results for the first six months of 2020
26 août 2020 09h51 HE | Biofrontera AG
Leverkusen, Germany, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today published its...
RWB-Wide-Logo.png
Red White & Bloom Brands Closes Agreement With High Times
11 juin 2020 07h00 HE | Red White & Bloom Brands Inc.
TORONTO, June 11, 2020 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB and OTC: TDRYD) (“RWB” or the “Company”) is pleased to announce that it has closed the previously announced...
The Movie Studio MVES LOGO.png
The Movie Studio Signs Agreement with FILMHUB for Licensing, Distribution of Motion Pictures
15 avr. 2020 07h00 HE | The Movie Studio
FORT LAUDERDALE, Fla., April 15, 2020 (GLOBE NEWSWIRE) -- via NetworkWire - The  Movie  Studio  Inc. (OTC: MVES), a vertically integrated motion picture production company, announces it has signed a...
Oncology Pharma and Kalos Therapeutics Expand Licensing Agreement for Exploring Kalos's Anti-Cancer Lead Drug in Treating COVID-19
06 avr. 2020 08h00 HE | Oncology Pharma, Inc.
SAN FRANCISCO, CA, April 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Oncology Pharma, Inc. (OTCPK: ONPH) and Kalos Therapeutics (“Kalos”) announced today that the companies amended the terms of...
logo.png
Global Technologies, Ltd is Pleased to Update Shareholders on its Recent Corporate Progress
26 févr. 2020 12h47 HE | Global Technologies, Ltd
ST. PETERSBURG, FL, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Global Technologies, Ltd (OTC Pink: GTLL), a former technology portfolio company that acquired nascent technology and related innovations,...
IncludeHealth Secures Licensing Agreement from Cincinnati Children’s Hospital Medical Center
18 déc. 2019 04h00 HE | IncludeHealth
Cincinnati, OHIO, Dec. 18, 2019 (GLOBE NEWSWIRE) -- IncludeHealth, an internationally recognized provider of inclusive digital health and performance technologies, and Cincinnati Children’s Hospital...
aksteel-logo.jpg
AK Steel Enters Licensing Agreement Involving Its ULTRALUME® PHS High Strength, High Formability Steel Product
28 oct. 2019 11h30 HE | AK Steel
WEST CHESTER, Ohio, Oct. 28, 2019 (GLOBE NEWSWIRE) -- AK Steel (NYSE: AKS) announced today that it has entered into a licensing agreement involving its aluminized boron press hardenable steel...
Dakshidin Corporation (DKSC), Signs LOI for Worldwide Exclusive Licensing Agreement
15 janv. 2019 09h56 HE | Dakshidin Corporation
LAS VEGAS, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Dakshidin Corporation (DKSC) announced today that it had signed a Letter of Intent for a worldwide exclusive licensing agreement with GenBio, a...